Screener
Vaxcyte, Inc. PCVX Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
FAQ
- What is Vaxcyte, Inc.'s invested capital?
- Vaxcyte, Inc. (PCVX) reported invested capital of $2.85B in Q1 2026.
- How has Vaxcyte, Inc.'s invested capital changed year-over-year?
- Vaxcyte, Inc.'s invested capital decreased by 3.0% year-over-year, from $2.94B to $2.85B.
- What is the long-term trend for Vaxcyte, Inc.'s invested capital?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s invested capital has grown at a 131.6% compound annual growth rate (CAGR), from -$39.46M to $2.63B.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Vaxcyte, Inc.'s invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude